Just before the end of 2025, an oral version of a GLP-1 drug specifically used for weight management moved much closer to ...

Industry Analysis Examines How Cost, Safety, and Access Considerations Shape Semaglutide Choices as MEDVi Lists Compounded ...

Complete Pricing Comparison Shows FDA-Approved Wegovy Access From $149 Oral to Ro's $199 Injectable Through Telehealth as 1 in 8 Americans Now Use GLP-1 MedicationsNEW YORK, Dec. 30, 2025 (GLOBE ...

NASA opens the International Space Station for scientists and researchers, inviting them to use the benefits of microgravity ...

A new type of lens approved by the FDA promises to slow nearsightedness in children. These specialized glasses, available in ...

A new FDA-approved treatment may help train the brain to ignore the ear ringing of tinnitus by combining sound stimulation ...

The FDA-approved trial in Arizona explores whole-mushroom psilocybin therapy for PTSD with first responders and veterans.

An Arizona Army veteran who spent years in military service is now part of a pioneering effort led by one of the country’s most prominent psychedelic researchers.

The United States Food and Drug Administration (FDA) has approved a new oral version of the weight loss medication Wegovy, ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a second generic form of mifepristone. HHS is reportedly reviewing mifepristone after state ...

MADISON (WKOW) -- Children ages 12 and older with sickle cell are now eligible for a newly FDA-approved treatment through the MACC Fund Center for Cancer and Blood Disorders at Children's Wisconsin.